Monday, August 07, 2006 10:44:59 AM
Does anyone have any more news on this. I Saw this news blip on Etrade this morning that was posted after the market close on friday.
LATE TRADING: Opinion Research Soars On Buyout Offer -2-
Dow Jones Newswires - August 04, 2006 5:00 PM ET
Related Quotes
Symbol Last Chg
CNC Trade 17.59 +0.24
DMRC Trade 6.36 +0.21
EMMS Trade 11.66 -2.86
GERN Trade 6.00 +0.01
IUSA Trade 8.78 -0.52
ORCI Trade 11.62 +5.42
Real time quote.
Shares of Geron Corp. (GERN) fell 2.2% to $5.86 after the biopharmaceutical company said it intended to sell up to $250 million in debt securities and stock, according to a filing with the Securities and Exchange Commission.
The Menlo Park, Calif., company said it intends to use the net proceeds from the sale for general corporate purposes, which may include funding research and development, increasing working capital, reducing debt, acquisitions or investments and capital expenditures.
Shares of Centene Corp. (CNC) inched up 0.9% to $17.50 after announcing its Indiana unit, Managed Health Services), was awarded a Indiana Medicaid managed care contract.
The contract, effective Jan. 1, hired Managed Health to manage a portion of the approximately 535,000 eligible Hoosier Healthwise members.
-Christopher Hinton; Dow Jones Newswires; 201-938-5285; christopher.hinton@dowjones.com
Recent GERN News
- Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 11/14/2024 02:31:41 PM
- Form SC 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 11/14/2024 11:25:29 AM
- Geron Corporation Announces Appointment of Joseph Eid, M.D. as Executive Vice President, Research and Development • Business Wire • 11/11/2024 09:30:00 PM
- Geron to Participate in the Stifel 2024 Healthcare Conference • Business Wire • 11/11/2024 02:00:00 PM
- Royalty Pharma to Acquire Royalty Interest in Geron’s RYTELO for $125 Million • GlobeNewswire Inc. • 11/07/2024 12:10:00 PM
- Geron Corporation Announces Up to $375 Million in Funding with Royalty Pharma and Pharmakon Advisors • Business Wire • 11/07/2024 12:01:00 PM
- Geron Corporation Reports Third Quarter 2024 Financial Results and Recent Business Highlights • Business Wire • 11/07/2024 12:00:00 PM
- Geron Announces New Data to be Presented at Upcoming ASH Annual Meeting Highlighting the Potential of RYTELO™ (imetelstat) in Myeloid Hematologic Malignancies • Business Wire • 11/05/2024 02:00:00 PM
- Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 10/17/2024 08:30:00 PM
- Geron to Announce Third Quarter 2024 Financial Results on November 7, 2024 • Business Wire • 10/15/2024 08:30:00 PM
- Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 09/19/2024 08:30:00 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 09/09/2024 08:35:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/09/2024 08:35:03 PM
- Geron Corporation Announces Appointment of Jim Ziegler as Chief Commercial Officer • Business Wire • 09/09/2024 08:15:00 PM
- Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 08/22/2024 08:30:00 PM
- Geron Corporation Reports Second Quarter 2024 Financial Results and Business Highlights • Business Wire • 08/08/2024 11:00:00 AM
- Geron Announces Updated NCCN Guidelines® Recommending RYTELO™ (imetelstat) for the Treatment of Symptomatic Anemia in Patients with Lower-Risk MDS • Business Wire • 07/26/2024 11:30:00 AM
- Geron Corporation Announces Chief Commercial Officer to Depart at End of August 2024 • Business Wire • 07/23/2024 08:15:00 PM
- Geron to Announce Second Quarter 2024 Financial Results on August 8, 2024 • Business Wire • 07/18/2024 08:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/10/2024 08:05:04 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 07/08/2024 07:44:18 PM
- Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 06/20/2024 08:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/12/2024 08:05:08 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/12/2024 08:05:04 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 06/10/2024 09:53:19 PM
Kona Gold Beverage, Inc. Updates Multi-Million Dollar Merger and Posts Over $1.2 Million in Q3 Revenues • KGKG • Nov 15, 2024 10:36 AM
HealthLynked Corp. Announces Third Quarter and Year-to-Date 2024 Results with Strategic Restructuring, Third-Party Debt Repayment, and Core Technology Focus • HLYK • Nov 15, 2024 8:00 AM
Alliance Creative Group (ACGX) Releases Q3 2024 Financial and Disclosure Report with an increase of over 100% in Net Income for 1st 9 months of 2024 vs 2023 • ACGX • Nov 14, 2024 8:30 AM
Unitronix Corp. Publishes Its Cryptocurrency Portfolio Strategy • UTRX • Nov 14, 2024 8:05 AM
Avant Technologies and Ainnova Tech Form Joint Venture to Advance Early Disease Detection Using Artificial Intelligence • AVAI • Nov 12, 2024 9:00 AM
Swifty Global Announces Launch of Swifty Sports IE, Expanding Sports Betting and Casino Services in the Irish Market • DRCR • Nov 12, 2024 9:00 AM